Purpose: Osteoarthritis (OA) is the most prevalent joint disease, leading to progressive degradation of the articular cartilage. To investigate precise molecular changes occurring in the cartilage during disease development, we used RNA sequencing (RNA-seq) to compare the transcriptome of OA and normal hip cartilage. Based on Next Generation DNA sequencing technology, RNA-seq is not only able to determine gene expression levels genome-wide but can also identify alternative splicing events, new classes of RNA and single nucleotide polymorphisms (SNPs). Here we have focused on expression analysis. Methods: Total RNA was isolated from human articular cartilage samples obtained from consented patients undergoing joint replacement surgery due to either end-stage hip OA or neck of femur fracture (NOF). 78-base paired-end sequencing was performed on an Illumina Genome Analyzer IIx according to the manufacturer's protocol. Sequencing reads were filtered to trim low quality ends before aligning them to known human genome transcript sequences using Novocraft Novoalign. Bioconductor package cqn was used to normalize read counts and minimize bias due to gene length and GC content. Samples were clustered according to their expression profiles to check quality of RNA samples and differentially expressed genes were identified using Bioconductor package edgeR. Function and pathway analyses were performed with the Ingenuity Pathway Analysis package. The results were compared and verified using the results from whole-genome microarray experiments. Results: On average, 54 million 78-base pair-end reads were produced for RNAs from each OA (n¼10) and NOF (n¼6) cartilage sample. At least 26% of transcripts in each sample had a coverage depth 0.9. Clear separation of OA and NOF samples in the hierarchical clustering result indicated the reliability of the expression profiles. In total, 1434 genes (P-values0.01, fold change -2 or 2) were identified as differentially expressed. Changes in the expression of these genes significantly correlated with equivalent changes in traditional microarray hybridization experiments (r ¼ 0.84) but revealed novel associations with a number of canonical pathways, such as IL-6 (P-value¼0.00036), HMGB1 (P-value¼0.001), toll-like receptor (P-value¼0.013) and BMP (P-value¼0.044) signaling. Conclusions: This is the first application of RNA-seq to investigate OA cartilage. Transcriptomes obtained with this method have excellent correlation with expression data from a microarray platform but also show improved sensitivity and the ability to detect a wider range of expression changes. This has allowed us to identify a number of additional pathogenic pathways associated with OA. With confirmation of the quality and reliability of the RNA-seq data, we will proceed to determine alternative splicing events, novel RNAs and other posttranscriptional events.
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SUBSTANTIAL ALTERATION OF POST-TRANSCRIPTIONAL GENE CONTROL IN CHONDROCYTES FROM OSTEOARTHRITIC JOINTS
Purpose: Regulation of mRNA decay rates offers cells a means of controlling not only gene expression levels but also gene responsiveness to altered transcriptional input. We have previously shown that important chondrocyte markers such as SOX9 and COL2A1 can be controlled post-transcriptionally in chondrocytes if exposed to cell stresses such as hyperosmolarity. Interestingly, recent evidence shows that molecules that are known to control mRNA decay, such as microRNAs, are regulated during osteoarthritis (OA). In this study we aimed to determine, for the first time, the effect of OA pathology on the rates of mRNA decay across the chondrocyte transcriptome. Methods: Human articular chondrocytes (HAC) were isolated from normal cartilage (N), macroscopically intact OA tissue (I) or macroscopically degenerate OA tissue (D) and used within 24 hours. An osteochondral sample from each specimen was collected to allow histological grading. RNA decay was measured using microarray analysis of HAC total RNA, which was collected 0, 1, 3 and 5 hours after treatment of the HAC with the transcription inhibitor actinomycin D. Transcriptome-wide mRNA half-lives were determined by linear regression and significant differences between the rates observed in different tissue sources was determined using student's t-test with false discovery rate testing. Gene ontology investigations were carried out using Ingenuity Pathway Analysis (IPA). Results: Initial examination of total mRNA expression levels (using the time 0 values of the decay curves) demonstrated significant differences in the expression of transcripts between normal and osteoarthritic cartilage (N vs. I and N vs. D), which in many instances involved regulation of the same genes. Interestingly, we found almost no significant difference in total mRNA expression between chondrocytes isolated from either intact vs. degenerate OA cartilage (I vs. D). Subsequent examination of the half-life of mRNA in chondrocytes from these different tissues also showed greater variation between the normal chondrocytes and the OA chondrocytes. However, in contrast to total RNA analysis, we detected high numbers of significantly regulated genes in comparisons between every group. (N vs. I ¼ 592, N vs. D ¼ 417, I vs. D ¼ 361). Despite demonstrating altered post-transcriptional control, most of these genes did not display overall regulation at their transcript level. Examination of the post-transcriptionally regulated genes using IPA indicated that pathways such as NFkB and JAK/STAT were affected through altered post-transcriptional control in OA, as well as pathways controlling cell cycle, apoptosis and extracellular matrix synthesis. Conclusions: The surprising find of this study is the large number of transcripts whose decay rates are altered in osteoarthritis; greater than the number of genes whose overall expression was regulated. These changes, despite the unchanged steady state expression of these genes in health and disease, provides evidence that OA substantially affects the regulatory dynamics that underpin gene expression levels and could consequently alter the genes' response to transcriptional stimulus. This might play an important role in the development and progression of OA pathology. Purpose: Cartilage homeostasis is regulated by several mechanisms that influence both anabolic and catabolic balance. Among them, the local activation of Wnt pathways plays a major role in chondrocyte activity which might be regulated by Wnt inhibitors. Sclerostin, a Wnt inhibitor mainly produced by osteocytes and hypertrophic chondrocytes, might participate to the crosstalk between bone and cartilage. Therefore, the aim of this study is to determine the effect of Sclerostin in chondrocyte function. Methods: Primary murine chondrocytes, isolated from long bone epiphysis of 6 day-old mice, were cultured with or without Wnt3a conditioned media (Wnt3aCM) and in the presence or absence of mouse recombinant Sclerostin. Proteoglycan release induced by Wnt was quantified in the supernatant of chondrocytes by a colorimetric assay. Activation and inhibition of Wnt pathway was shown by the translocation of b-catenin (IF, TOP-GAL activity). BrdU and Tunel assays were performed to test the effect of Wnt and Sclerostin on cell proliferation and apoptosis. Chondrocyte differentiation induced by Sclerostin was investigated by RT-qPCR through the relative expression of type II and X collagen, Sox9, aggrecan, MMP-3, MMP-13 ADAMTS-4 & 5 genes. Results: Wnt3aCM reduced proteoglycan release in a dose-dependent manner and was rescued by Sclerostin (20ng/ml). This dose was chosen for the following experiments. Wnt inhibited the gene expression of collagen type II (X18-fold), Sox9 (X140 fold) and Aggrecan (X90-fold) and increases the gene expression of metalloproteinases such as Adamts-4 (X5-fold), Adamts-5 (X5.5-fold), MMP3 (X7-fold) and MMP13 (X6.6-fold). Sclerostin was able to inhibit the nuclear translocation of b-catenin induced by Wnt, but failed to exert any effect in the proliferation or apoptosis in primary chondrocytes regardless of Wnt. However, Wnt3a increased the gene expression of collagen type X (X3-fold) which was abolished by Sclerostin (X1.6-fold). Sclerostin significantly inhibited the Wnt-induced increase of catabolic genes (X1.7-fold Adamts-4, X1.6-fold Adamts-5, X3.4-fold MMP3 and X4-fold MMP13) and rescues partially the expression of anabolic genes (X5-fold collagen type II, X6-fold Sox-9 and X11-fold Aggrecan). In addition, Wnt3a induced the expression of Abstracts / Osteoarthritis and Cartilage 20 (2012) S10-S53 S43
